Butyric Acid

Butyric Acid

SCHEMBL4897545

CC(O)COC(C)CO.CCCC(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
TDP1 Q9NUW8 3/20 0.46
MAPT P10636 1/20 0.39
HSD17B10 Q99714 2/20 0.35
FFAR4 Q5NUL3 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
FFAR1 O14842 2/20 0.33
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33
AKR1B1 P15121 1/20 0.33
LMNA P02545 1/20 0.33
PPARG P37231 6/20 0.32
PPARD Q03181 6/20 0.32
PPARA Q07869 6/20 0.32
HDAC11 Q96DB2 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL29707584 0.97 FFAR3 (0.43) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL181699 0.97 FFAR3 (0.43) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL181497 0.97 FFAR3 (0.43) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL29008437 0.91 TDP1 (0.41) FFAR3HDAC3HDAC1HDAC2HDAC8
Valeric Acid SCHEMBL25240810 0.90 AKR1B1 (0.44) TDP1MAPTHSD17B10FFAR4MEN1
Hexanoate SCHEMBL28739919 0.88 AKR1B1 (0.52) TDP1MAPTHSD17B10FFAR4MEN1
Hexanoate SCHEMBL1171519 0.88 AKR1B1 (0.52) TDP1MAPTHSD17B10FFAR4MEN1
Glutarate SCHEMBL20504491 0.87 SLC22A6 (0.41) TDP1MAPTFFAR4FFAR1AKR1B1
Succinic Acid SCHEMBL28693360 0.87 TDP1 (0.43) TDP1MAPTLMNA
Adipic Acid SCHEMBL4595421 0.87 LMNA (0.41) TDP1MAPTHSD17B10FFAR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260102368-A1 NOVEL FEED ADDITIVES COMPRISING FATTY ACID ESTERS AND RELATED METHODS TO IMPROVE ANIMAL GROWTH PERFORMANCE AND HEALTH KEMIN INDUSTRIES, INC. (US) 2026-04-16 US disclosed
US-8252371-B2 Injecting a foam support containing corosion resistant material; railroad wagons; one step SOCIETE NATIONALE DES CHEMINS DE FER FRANCAIS (FR) 2012-08-28 US disclosed
US-20080199608-A1 Method for the anticorrosive Treatment of Hollow Bodies, Method for Producing a Metallic Structure Treated According to Said Method, and Method for Maintaining the Structure SOCIETE NATIONALE DES CHEMINS DE FER FRANCAIS (FR) 2008-08-21 US disclosed
CN-1107048-C Process for producing alkylene glycol monoalkyl ether carboxylate CELANESE INT CORP (US) 2003-04-30 CN disclosed
CN-1275974-A Continuous process for the production of carboxylic acid esters of alkylene glycol monoalkyl ethers CELANESE INT CORP (US) 2000-12-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260102368-A1 NOVEL FEED ADDITIVES COMPRISING FATTY ACID ESTERS AND RELATED METHODS TO IMPROVE ANIMAL GROWTH PERFORMANCE AND HEALTH FABP2, VIP, SLC27A2 FFAR3 24/4885HDAC3 2730/4885HDAC1 3116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.